Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 790652, 9 pages
http://dx.doi.org/10.1155/2015/790652
Research Article

in Drinking Water Activated NF-κB Signal Pathway and Increased TGF-β and IL-1β Expressions in Bladder Epithelial Cells of Rats

Department of Environmental and Occupational Health, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, China

Received 1 September 2015; Accepted 19 October 2015

Academic Editor: Giuseppe Valacchi

Copyright © 2015 Siqi Cao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Yamamoto, Y. Konishi, T. Matsuda et al., “Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid), in F344/DuCrj rats after pretreatment with five carcinogens,” Cancer Research, vol. 55, no. 6, pp. 1271–1276, 1995. View at Google Scholar · View at Scopus
  2. M. Wei, H. Wanibuchi, K. Morimura et al., “Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors,” Carcinogenesis, vol. 23, no. 8, pp. 1387–1397, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. L. L. Arnold, M. Eldan, A. Nyska, M. van Gemert, and S. M. Cohen, “Dimethylarsinic acid: results of chronic toxicity/oncogenicity studies in F344 rats and in B6C3F1 mice,” Toxicology, vol. 223, no. 1-2, pp. 82–100, 2006. View at Publisher · View at Google Scholar
  4. International Agency for Research on Cancer (IARC), “Arsenic in drinking water,” in Some Drinking Water Disinfectants and Contaminants, Including Arsenic, vol. 84 of Monographs on the Evaluation of Carcinogenic Risk to Humans, pp. 269–477, International Agency for Research on Cancer, 2004. View at Google Scholar
  5. Z. Lin, L. Shengnan, W. Fei et al., “Dimethylarsinic acid (DMAV) changed the expressions of proliferative related factors and secretion of inflammatory cytokines in rat bladder,” Journal of Applied Toxicology, vol. 35, no. 2, pp. 133–141, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Levidou, A. A. Saetta, P. Korkolopoulou et al., “Clinical significance of nuclear factor (NF)-κB levels in urothelial carcinoma of the urinary bladder,” Virchows Archiv, vol. 452, no. 3, pp. 295–304, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. A. S. Baldwin Jr., “The NF-kappa B and I kappa B proteins: new discoveries and insights,” Annual Review of Immunology, vol. 14, pp. 649–683, 1996. View at Google Scholar
  8. M. J. May and S. Ghosh, “IκB kinases: kinsmen with different crafts,” Science, vol. 284, no. 5412, pp. 271–273, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Dejardin, V. Deregowski, M. Chapelier et al., “Regulation of NF-κB activity by IκB-related proteins in adenocarcinoma cells,” Oncogene, vol. 18, no. 16, pp. 2567–2577, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Karin, Y. Cao, F. R. Greten, and Z.-W. Li, “NF-kappaB in cancer: from innocent bystander to major culprit,” Nature Reviews Cancer, vol. 2, no. 4, pp. 301–310, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. F. R. Greten, L. Eckmann, T. F. Greten et al., “IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer,” Cell, vol. 118, no. 3, pp. 285–296, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Kontos, G. Sotiropoulou-Bonikou, A. Kominea, M. Melachrinou, E. Balampani, and D. Bonikos, “Coordinated increased expression of cyclooxygenase2 and nuclear factor κB is a steady feature of urinary bladder carcinogenesis,” Advances in Urology, vol. 2010, Article ID 871356, 8 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Wei, H. Wanibuchi, S. Yamamoto, W. Li, and S. Fukushima, “Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats,” Carcinogenesis, vol. 20, no. 9, pp. 1873–1876, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Wanibuchi, S. Yamamoto, H. Chen et al., “Promoting effects of dimethylarsinic acid on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats,” Carcinogenesis, vol. 17, no. 11, pp. 2435–2439, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Liu, F. Wang, L. Yan et al., “Oxidative stress and MAPK involved into ATF2 expression in immortalized human urothelial cells treated by arsenic,” Archives of Toxicology, vol. 87, no. 6, pp. 981–989, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Wang, S. Liu, S. Xi et al., “Arsenic induces the expressions of angiogenesis-related factors through PI3K and MAPK pathways in SV-HUC-1 human uroepithelial cells,” Toxicology Letters, vol. 222, no. 3, pp. 303–311, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. G. J. Ahlborn, G. M. Nelson, W. O. Ward et al., “Dose response evaluation of gene expression profiles in the skin of K6/ODC mice exposed to sodium arsenite,” Toxicology and Applied Pharmacology, vol. 227, no. 3, pp. 400–416, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. T. D. Gilmore, “Introduction to NF-κB: players, pathways, perspectives,” Oncogene, vol. 25, no. 51, pp. 6680–6684, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. M. M. Chaturvedi, B. Sung, V. R. Yadav, R. Kannappan, and B. B. Aggarwal, “NF-κB addiction and its role in cancer: ‘one size does not fit all’,” Oncogene, vol. 30, no. 14, pp. 1615–1630, 2011. View at Publisher · View at Google Scholar
  20. S. Huang, S. Guo, F. Guo et al., “CD44v6 expression in human skin keratinocytes as a possible mechanism for carcinogenesis associated with chronic arsenic exposure,” European Journal of Histochemistry, vol. 57, no. 1, article e1, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Jiang, Y. Li, Y. Xu et al., “EMT and CSC-like properties mediated by the IKKβ/IκBα/RelA signal pathway via the transcriptional regulator, Snail, are involved in the arsenite-induced neoplastic transformation of human keratinocytes,” Archives of Toxicology, vol. 87, no. 6, pp. 991–1000, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. Y.-C. Hseu, K. J. Senthil Kumar, C.-S. Chen et al., “Humic acid in drinking well water induces inflammation through reactive oxygen species generation and activation of nuclear factor-κB/activator protein-1 signaling pathways: a possible role in atherosclerosis,” Toxicology and Applied Pharmacology, vol. 274, no. 2, pp. 249–262, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. L. E. Olsson, M. A. Wheeler, W. C. Sessa, and R. M. Weiss, “Bladder instillation and intraperitoneal injection of Escherichia coli lipopolysaccharide up-regulate cytokines and iNOS in rat urinary bladder,” Journal of Pharmacology and Experimental Therapeutics, vol. 284, no. 3, pp. 1203–1208, 1998. View at Google Scholar · View at Scopus
  24. S. Holdenrieder and P. Stieber, “Apoptotic markers in cancer,” Clinical Biochemistry, vol. 37, no. 7, pp. 605–617, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Celec, “Nuclear factor κ B-molecular biomedicine: the next generation,” Biomedicine and Pharmacotherapy, vol. 58, no. 6-7, pp. 365–371, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Karin and F. R. Greten, “NF-kappaB: linking inflammation and immunity to cancer development and progression,” Nature Reviews Immunology, vol. 5, no. 10, pp. 749–759, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. M. U. Rehman, M. Tahir, A. Q. Khan et al., “Chrysin suppresses renal carcinogenesis via amelioration of hyperproliferation, oxidative stress and inflammation: plausible role of NF-κB,” Toxicology Letters, vol. 216, no. 2-3, pp. 146–158, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Y. W. Bourguignon, G. Wong, C. A. Earle, and W. Xia, “Interaction of low molecular weight hyaluronan with CD44 and toll-like receptors promotes the actin filament-associated protein 110-actin binding and MyD88-NFκB signaling leading to proinflammatory cytokine/chemokine production and breast tumor invasion,” Cytoskeleton, vol. 68, no. 12, pp. 671–693, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Ruiz-Deya, S. C. Sikka, R. Thomas, and A. B. Abdel-Mageed, “Potential role for the nuclear transcription factor NF-κB in the pathogenesis of ureteropelvic junction obstruction,” Journal of Endourology, vol. 16, no. 8, pp. 611–615, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Zhu, L. Zhang, S. Ling et al., “Scropolioside B inhibits IL-1β and cytokines expression through NF-κB and inflammasome NLRP3 pathways,” Mediators of Inflammation, vol. 2014, Article ID 819053, 10 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. I. Chefetz, J. C. Holmberg, A. B. Alvero, I. Visintin, and G. Mor, “Inhibition of Aurora-a kinase induces cell cycle arrest in epithelial ovarian cancer stem cells by affecting NFκB pathway,” Cell Cycle, vol. 10, no. 13, pp. 2206–2214, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. A. B. Alvero, R. Chen, H.-H. Fu et al., “Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance,” Cell Cycle, vol. 8, no. 1, pp. 158–166, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. X.-C. Wang, R. Saban, J. H. Kaysen et al., “Nuclear factor kappa B mediates lipopolysaccharide-induced inflammation in the urinary bladder,” Journal of Urology, vol. 163, no. 3, pp. 993–998, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Ben-Neriah and M. Karin, “Inflammation meets cancer, with NF-κB as the matchmaker,” Nature Immunology, vol. 12, no. 8, pp. 715–723, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. D. G. Jackson-Bernitsas, H. Ichikawa, Y. Takada et al., “Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-κB activation and proliferation in human head and neck squamous cell carcinoma,” Oncogene, vol. 26, no. 10, pp. 1385–1397, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Sakurai, H. Miyoshi, W. Toriumi, and T. Sugita, “Functional interactions of transforming growth factor β-activated kinase 1 with IκB kinases to stimulate NF-κB activation,” Journal of Biological Chemistry, vol. 274, no. 15, pp. 10641–10648, 1999. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Takaesu, S. Kishida, A. Hiyama et al., “TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway,” Molecular Cell, vol. 5, no. 4, pp. 649–658, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Freudlsperger, Y. Bian, S. Contag Wise et al., “TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers,” Oncogene, vol. 32, no. 12, pp. 1549–1559, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. G. M. Gordon, D. R. Ledee, W. J. Feuer, and M. E. Fini, “Cytokines and signaling pathways regulating matrix metalloproteinase-9 (MMP-9) expression in corneal epithelial cellsy,” Journal of Cellular Physiology, vol. 221, no. 2, pp. 402–411, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. W. Cui, D. J. Fowlis, S. Bryson et al., “TGFβ1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice,” Cell, vol. 86, no. 4, pp. 531–542, 1996. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Kim, J.-A. Choi, and J.-H. Kim, “Ras promotes transforming growth factor-β(TGF-β)-induced epithelial-mesenchymal transition via a leukotriene B4 receptor-2-linked cascade in mammary epithelial cells,” The Journal of Biological Chemistry, vol. 289, no. 32, pp. 22151–22160, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. M. C. Catley, J. E. Chivers, L. M. Cambridge et al., “IL-1beta dependent activation of NF-kappaB mediates PGE2 release via the expression of cyclooxygenase-2 and microsomal prostaglandin E synthase,” FEBS Letters, vol. 547, no. 1–3, pp. 75–79, 2003. View at Publisher · View at Google Scholar · View at Scopus